Form 4: Core Scientific CEO Adam Sullivan Reports Stock Transactions

Core Scientific CEO Adam Sullivan reported transactions involving restricted stock units and tax withholdings on March 31, 2026.

Summary

• Adam Sullivan, CEO of Core Scientific, Inc., filed a Form 4 detailing stock transactions on March 31, 2026.
• He acquired 741,545 shares of common stock valued at $0, representing a performance-based restricted stock unit (PSU) grant.
• These PSUs vest based on performance criteria and continued service, with the Compensation Committee certifying satisfaction of criteria and approving settlement on March 31, 2026.
• Additionally, 315,307 shares were disposed of at a price of $14.96 per share, totaling $4,717,500.22, to cover tax withholding obligations upon the vesting of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine executive compensation transactions rather than significant strategic shifts or performance indicators.

Positives

• CEO Adam Sullivan received a significant grant of 741,545 performance-based restricted stock units, indicating potential future value tied to company performance.
• The Compensation Committee certified the satisfaction of performance criteria for these PSUs, suggesting the company is meeting its strategic goals.
• The settlement of PSUs and subsequent tax withholding demonstrates ongoing operational activity and executive compensation realization.

Negatives

• 315,307 shares were disposed of to cover tax withholding obligations, representing a reduction in the CEO's direct holdings.
• The disposal price of $14.96 per share, while not explicitly negative in isolation, is a factual transaction detail.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance. However, the vesting of PSUs based on performance criteria implies an expectation of continued achievement of company objectives.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The settlement of performance-based restricted stock units by the CEO of Core Scientific (CORZ) is a common practice for executive compensation, reflecting the company's operational status and its approach to incentivizing leadership.

Stakeholder Impact

• Shareholders: The transaction details the CEO's compensation realization and potential dilution from equity awards, which is standard for publicly traded companies with stock-based compensation plans.
• Employees: The successful certification of performance criteria for PSUs may indirectly signal positive company performance, potentially benefiting employees through morale and future opportunities.
• Management: The CEO's compensation is directly impacted by the vesting and settlement of these PSUs.

Key Dates

Keywords

Form 4, SEC Filing, Core Scientific, CORZ, Adam Sullivan, CEO, Stock Transaction, Restricted Stock Units, PSU, Beneficial Ownership, Tax Withholding